Related references
Note: Only part of the references are listed.Baricitinib as potential treatment for 2019-nCoV acute respiratory disease
Peter Richardson et al.
LANCET (2020)
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
Roujian Lu et al.
LANCET (2020)
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
Nanshan Chen et al.
LANCET (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou et al.
NATURE (2020)
Clinical Characteristics of Coronavirus Disease 2019 in China
W. Guan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
A Novel Coronavirus from Patients with Pneumonia in China, 2019
Na Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Hematological findings and complications of COVID-19
Evangelos Terpos et al.
AMERICAN JOURNAL OF HEMATOLOGY (2020)
Severe Acute Respiratory Syndrome Coronavirus 2 Infection and the Upper Limb Deep Vein Thrombosis Risk
Antonio Bozzani et al.
ANNALS OF VASCULAR SURGERY (2020)
Thromboembolic risk and anticoagulant therapy in COVID-19 patients: emerging evidence and call for action
Anastasios Kollias et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure
Evangelos J. Giamarellos-Bourboulis et al.
CELL HOST & MICROBE (2020)
Prominent changes in blood coagulation of patients with SARS-CoV-2 infection
Huan Han et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2020)
Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019
Juanjuan Zhao et al.
CLINICAL INFECTIOUS DISEASES (2020)
Coagulopathy of Coronavirus Disease 2019
Toshiaki Iba et al.
CRITICAL CARE MEDICINE (2020)
Immunology of COVID-19: Current State of the Science
Nicolas Vabret et al.
IMMUNITY (2020)
High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study
Julie Helms et al.
INTENSIVE CARE MEDICINE (2020)
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
Chenguang Shen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Prevalence, Severity and Mortality associated with COPD and Smoking in patients with COVID-19: A Rapid Systematic Review and Meta-Analysis
Jaber S. Alqahtani et al.
PLOS ONE (2020)
Effectiveness of convalescent plasma therapy in severe COVID-19 patients
Kai Duan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
The profile of peripheral blood lymphocyte subsets and serum cytokines in children with 2019 novel coronavirus pneumonia
Hui Li et al.
JOURNAL OF INFECTION (2020)
Effect of regular intravenous immunoglobulin therapy on prognosis of severe pneumonia in patients with COVID-19
Yun Xie et al.
JOURNAL OF INFECTION (2020)
Effect of Convalescent Plasma Therapy on Viral Shedding and Survival in Patients With Coronavirus Disease 2019
Qing-Lei Zeng et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Cytokine release syndrome in severe COVID-19
John B. Moore et al.
SCIENCE (2020)
Convalescent Plasma: Therapeutic Hope or Hopeless Strategy in the SARS-CoV-2 Pandemic
H. Cliff Sullivan et al.
TRANSFUSION MEDICINE REVIEWS (2020)
Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases
Cynthia Magro et al.
TRANSLATIONAL RESEARCH (2020)
ISTH interim guidance on recognition and management of coagulopathy in COVID-19
Jecko Thachil et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Heparin resistance in COVID-19 patients in the intensive care unit
D. White et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2020)
Why tocilizumab could be an effective treatment for severe COVID-19?
Binqing Fu et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2020)
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Fei Zhou et al.
LANCET (2020)
SARS-CoV-2 and viral sepsis: observations and hypotheses
Hui Li et al.
LANCET (2020)
Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients
Jin Liu et al.
EBIOMEDICINE (2020)
Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19
Irani Thevarajan et al.
NATURE MEDICINE (2020)
Increased ACE2 Expression in Bronchial Epithelium of COPD Patients who are Overweight
Andrew Higham et al.
OBESITY (2020)
High Prevalence of Obesity in Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Requiring Invasive Mechanical Ventilation
Arthur Simonnet et al.
OBESITY (2020)
Interleukin-6 blockade treatment for COVID-19 associated cytokine release syndrome in a patient with poorly controlled chronic myeloid leukaemia
Amita Ranger et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Protective immunity after COVID-19 has been questioned: What can we do without SARS-CoV-2-IgG detection?
Juliana Gil Melgaco et al.
CELLULAR IMMUNOLOGY (2020)
Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort study
Danying Liao et al.
LANCET HAEMATOLOGY (2020)
Coagulation abnormalities and thrombosis in patients with COVID-19
Marcel Levi et al.
LANCET HAEMATOLOGY (2020)
Reappearance of effector T cells is associated with recovery from COVID-19
Ivan Odak et al.
EBIOMEDICINE (2020)
SARS-CoV-2 T cell immunity: Specificity, function, durability, and role in protection
Daniel M. Altmann et al.
SCIENCE IMMUNOLOGY (2020)
Immunosenescence exacerbates the COVID-19
Claudio Napoli et al.
ARCHIVES OF GERONTOLOGY AND GERIATRICS (2020)
Innate immunity in COVID-19 patients mediated by NKG2A receptors, and potential treatment using Monalizumab, Cholroquine, and antiviral agents
Ahmed Yaqinuddin et al.
MEDICAL HYPOTHESES (2020)
Epigenetic susceptibility to severe respiratory viral infections and its therapeutic implications: a narrative review
Ettore Crimi et al.
BRITISH JOURNAL OF ANAESTHESIA (2020)
Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China
Xin Xu et al.
NATURE MEDICINE (2020)
Immune-mediated approaches against COVID-19
Helena F. Florindo et al.
NATURE NANOTECHNOLOGY (2020)
Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications
Divij Mathew et al.
SCIENCE (2020)
Severe COVID-19 infection associated with endothelial activation
Robert Escher et al.
THROMBOSIS RESEARCH (2020)
Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19 The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial
Derek C. Angus et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Anticoagulation, Bleeding, Mortality, and Pathology in Hospitalized Patients With COVID-19
Girish N. Nadkarni et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Impact of tocilizumab administration on mortality in severe COVID-19
Andrew Tsai et al.
SCIENTIFIC REPORTS (2020)
Obesity as a predictor for a poor prognosis of COVID-19: A systematic review
Alice Tamara et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2020)
Cardiovascular involvement during COVID-19 and clinical implications in elderly patients. A review
Claudio Napoli et al.
ANNALS OF MEDICINE AND SURGERY (2020)
Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study
Giulio Cavalli et al.
LANCET RHEUMATOLOGY (2020)
COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation
Wolfgang Miesbach et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2020)
Clinical efficacy of intravenous immunoglobulin therapy in critical ill patients with COVID-19: a multicenter retrospective cohort study
Ziyun Shao et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2020)
Update on the use of immunoglobulin in human disease: A review of evidence
Elena E. Perez et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Macrophage activation-like syndrome: an immunological entity associated with rapid progression to death in sepsis
Evdoxia Kyriazopoulou et al.
BMC MEDICINE (2017)
IL-6 down-regulates HLA class II expression and IL-12 production of human dendritic cells to impair activation of antigen-specific CD4+ T cells
Yosuke Ohno et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)
Inflammation and Immune Response in COPD: Where Do We Stand?
Nikoletta Rovina et al.
MEDIATORS OF INFLAMMATION (2013)
Neutralizing Antibodies and Pathogenesis of Hepatitis C Virus Infection
Samira Fafi-Kremer et al.
VIRUSES-BASEL (2012)
Share Paper
